- Home
- INDP vs IBO Comparison
INDP vs IBO Comparison
Compare INDP & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- IBO
- Stock Information
- Founded
- INDP 2000
- IBO 2018
- Country
- INDP United States
- IBO United States
- Employees
- INDP N/A
- IBO N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- IBO
- Sector
- INDP Health Care
- IBO
- Exchange
- INDP Nasdaq
- IBO NYSE
- Market Cap
- INDP 5.0M
- IBO 5.8M
- IPO Year
- INDP N/A
- IBO 2024
- Fundamental
- Price
- INDP $11.12
- IBO $0.76
- Analyst Decision
- INDP Strong Buy
- IBO
- Analyst Count
- INDP 2
- IBO 0
- Target Price
- INDP $8.50
- IBO N/A
- AVG Volume (30 Days)
- INDP 689.8K
- IBO 23.2M
- Earning Date
- INDP 08-11-2025
- IBO 08-23-2025
- Dividend Yield
- INDP N/A
- IBO N/A
- EPS Growth
- INDP N/A
- IBO N/A
- EPS
- INDP N/A
- IBO N/A
- Revenue
- INDP N/A
- IBO N/A
- Revenue This Year
- INDP N/A
- IBO N/A
- Revenue Next Year
- INDP N/A
- IBO N/A
- P/E Ratio
- INDP N/A
- IBO N/A
- Revenue Growth
- INDP N/A
- IBO N/A
- 52 Week Low
- INDP $7.56
- IBO $0.36
- 52 Week High
- INDP $67.48
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- INDP 98.13
- IBO N/A
- Support Level
- INDP $0.31
- IBO N/A
- Resistance Level
- INDP $0.71
- IBO N/A
- Average True Range (ATR)
- INDP 0.07
- IBO 0.00
- MACD
- INDP 0.77
- IBO 0.00
- Stochastic Oscillator
- INDP 99.09
- IBO 0.00
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.